Previous close | 12.93 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 682 |
Market cap | 2.818M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Viridian Therapeutics ( NASDAQ:VRDN ) Full Year 2023 Results Key Financial Results Net loss: US$237.7m (loss widened by...
Insiders who bought US$262k worth of Viridian Therapeutics, Inc.'s ( NASDAQ:VRDN ) stock at an average buy price of...